Covered recipient · General Payments record
SARMELA T SUNDER
Allopathic & Osteopathic Physicians Otolaryngology Otolaryngology/Facial Plastic Surgery
General Payments · PY2018–2024
$85,435.70
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,250.00 | 2 |
| Food and Beverage | $813.05 | 15 |
| Travel and Lodging | $492.52 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $2,872.66 | 9 |
| REVANCE THERAPEUTICS, INC. | $416.95 | 7 |
| Galderma Laboratories, L.P. | $265.96 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $1,800.00 | 01/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106183623 | CMS |
| ABBVIE INC. | $450.00 | 07/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106183625 | CMS |
| ABBVIE INC. | $246.26 | 09/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106183627 | CMS |
| ABBVIE INC. | $18.74 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106183629 | CMS |
| ABBVIE INC. | $246.26 | 09/21/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1106183631 | CMS |
| ABBVIE INC. | $48.88 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106183633 | CMS |
| ABBVIE INC. | $39.37 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106183635 | CMS |
| ABBVIE INC. | $18.74 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106183637 | CMS |
| ABBVIE INC. | $4.41 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106183639 | CMS |
| Galderma Laboratories, L.P. | $23.15 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145331043 | CMS |
| Galderma Laboratories, L.P. | $50.31 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145331045 | CMS |
| Galderma Laboratories, L.P. | $192.50 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145331047 | CMS |
| REVANCE THERAPEUTICS, INC. | $25.23 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930259 | CMS |
| REVANCE THERAPEUTICS, INC. | $150.00 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930261 | CMS |
| REVANCE THERAPEUTICS, INC. | $21.08 | 06/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930263 | CMS |
| REVANCE THERAPEUTICS, INC. | $26.82 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930265 | CMS |
| REVANCE THERAPEUTICS, INC. | $12.62 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930267 | CMS |
| REVANCE THERAPEUTICS, INC. | $34.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930269 | CMS |
| REVANCE THERAPEUTICS, INC. | $146.44 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147930271 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.